PFIZER INC Cost of Revenue
PFIZER INC (PFE) reported Cost of Revenue of $4.09 billion for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-04
- PFIZER INC cost of goods and services sold for the quarter ending 2026-06-28 was $4.09B, a 8.31% increase year-over-year.
- PFIZER INC cost of goods and services sold for the quarter ending 2026-03-29 was $3.55B, a 24.71% increase year-over-year.
- PFIZER INC cost of goods and services sold for the quarter ending 2025-12-31 was $5.27B, a 10.78% decline year-over-year.
- PFIZER INC cost of goods and services sold for the quarter ending 2025-09-28 was $4.17B, a 20.73% decline year-over-year.
- PFIZER INC cost of goods and services sold for fiscal 2025 was $16.07B, a 9.99% decline from fiscal 2024.
- PFIZER INC cost of goods and services sold for fiscal 2024 was $17.85B, a 28.46% decline from fiscal 2023.
- PFIZER INC cost of goods and services sold for fiscal 2023 was $24.95B, a 27.34% decline from fiscal 2022.
- PFIZER INC cost of goods and services sold for fiscal 2022 was $34.34B, a 11.43% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | $4.09B 10-Q · filed 2026-08-04 | $7.64B 10-Q · filed 2026-08-04 | $12.91B derived: sum of 3 quarters · filed 2026-08-04 | $17.08B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-29 | $3.55B 10-Q · filed 2026-05-05 | $8.82B derived: sum of 2 quarters · filed 2026-05-05 | $12.99B derived: sum of 3 quarters · filed 2026-05-05 | $16.77B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $5.27B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.44B derived: sum of 2 quarters · filed 2026-02-26 | $13.22B derived: sum of 3 quarters · filed 2026-08-04 | $16.07B 10-K · filed 2026-02-26 | ||||
| 2025-09-28 | $4.17B 10-Q · filed 2025-11-04 | $7.95B derived: sum of 2 quarters · filed 2026-08-04 | $10.79B 10-Q · filed 2025-11-04 | $16.70B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-29 | $3.78B 10-Q · filed 2026-08-04 | $6.62B 10-Q · filed 2026-08-04 | $12.53B derived: sum of 3 quarters · filed 2026-08-04 | $17.80B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-30 | $2.85B 10-Q · filed 2026-05-05 | $8.75B derived: sum of 2 quarters · filed 2026-05-05 | $14.02B derived: sum of 3 quarters · filed 2026-05-05 | $17.32B derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $5.91B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.17B derived: sum of 2 quarters · filed 2026-02-26 | $14.47B derived: sum of 3 quarters · filed 2026-02-26 | $17.85B 10-K · filed 2026-02-26 | ||||
| 2024-09-29 | $5.26B 10-Q · filed 2025-11-04 | $8.56B derived: sum of 2 quarters · filed 2025-11-04 | $11.94B 10-Q · filed 2025-11-04 | $19.50B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $3.30B 10-Q · filed 2025-08-05 | $6.68B 10-Q · filed 2025-08-05 | $14.24B derived: sum of 3 quarters · filed 2026-02-26 | $23.51B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $3.38B 10-Q · filed 2025-05-05 | $10.94B derived: sum of 2 quarters · filed 2026-02-26 | $20.21B derived: sum of 3 quarters · filed 2026-02-26 | $23.45B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $7.56B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $16.83B derived: sum of 2 quarters · filed 2026-02-26 | $20.07B derived: sum of 3 quarters · filed 2026-02-26 | $24.95B 10-K · filed 2026-02-26 | ||||
| 2023-10-01 | $9.27B 10-Q · filed 2024-11-04 | $12.51B derived: sum of 2 quarters · filed 2024-11-04 | $17.39B 10-Q · filed 2024-11-04 | $27.04B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-07-02 | $3.24B 10-Q · filed 2024-08-05 | $8.12B 10-Q · filed 2024-08-05 | $17.77B derived: sum of 3 quarters · filed 2025-02-27 | $23.83B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-04-02 | $4.89B 10-Q · filed 2024-05-08 | $14.53B derived: sum of 2 quarters · filed 2025-02-27 | $20.60B derived: sum of 3 quarters · filed 2025-02-27 | $29.25B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $9.65B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $15.71B derived: sum of 2 quarters · filed 2025-02-27 | $24.36B derived: sum of 3 quarters · filed 2025-02-27 | $34.34B 10-K · filed 2025-02-27 | ||||
| 2022-10-02 | $6.06B 10-Q · filed 2023-11-08 | $14.71B derived: sum of 2 quarters · filed 2023-11-08 | $24.70B 10-Q · filed 2023-11-08 | $34.43B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-07-03 | $8.65B 10-Q · filed 2023-08-09 | $18.63B 10-Q · filed 2023-08-09 | $28.37B derived: sum of 3 quarters · filed 2024-02-22 | $38.30B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-04-03 | $9.98B 10-Q · filed 2023-05-10 | $19.72B derived: sum of 2 quarters · filed 2024-02-22 | $29.65B derived: sum of 3 quarters · filed 2024-02-22 | $36.65B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $9.74B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $19.67B derived: sum of 2 quarters · filed 2024-02-22 | $26.66B derived: sum of 3 quarters · filed 2024-02-22 | $30.82B 10-K · filed 2024-02-22 | ||||
| 2021-10-03 | $9.93B 10-Q · filed 2022-11-09 | $9.97B 10-Q · filed 2021-11-12 | $16.93B derived: sum of 2 quarters · filed 2022-11-09 | $21.09B 10-Q · filed 2022-11-09 | $21.23B 10-Q · filed 2021-11-12 | $23.80B derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-07-04 | $7.00B 10-Q · filed 2022-08-10 | $7.05B 10-Q · filed 2021-08-12 | $11.15B 10-Q · filed 2022-08-10 | $11.26B 10-Q · filed 2021-08-12 | $13.86B derived: sum of 3 quarters · filed 2023-02-23 | $15.87B derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-04-04 | $4.16B 10-Q · filed 2022-05-11 | $4.21B 10-Q · filed 2021-05-13 | $6.87B derived: sum of 2 quarters · filed 2023-02-23 | $8.88B derived: sum of 3 quarters · filed 2023-02-23 | $10.70B derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2020-12-31 | $2.71B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $4.72B derived: sum of 2 quarters · filed 2023-02-23 | $6.54B derived: sum of 3 quarters · filed 2023-02-23 | $8.48B 10-K · filed 2023-02-23 | $8.69B 10-K · filed 2021-02-25 | |||
| 2020-09-27 | $2.01B 10-Q · filed 2021-11-12 | $2.53B 10-Q · filed 2020-11-05 | $3.83B derived: sum of 2 quarters · filed 2021-11-12 | $5.77B 10-Q · filed 2021-11-12 | $7.19B 10-Q · filed 2020-11-05 | $6.22B derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-06-28 | $1.83B 10-Q · filed 2021-08-12 | $2.28B 10-Q · filed 2020-08-06 | $3.77B 10-Q · filed 2021-08-12 | $4.66B 10-Q · filed 2020-08-06 | $4.21B derived: sum of 3 quarters · filed 2022-02-24 | $6.81B derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-03-29 | $1.94B 10-Q · filed 2021-05-13 | $2.38B 10-Q · filed 2020-05-07 | $2.38B derived: sum of 2 quarters · filed 2022-02-24 | $4.99B derived: sum of 3 quarters · filed 2022-02-24 | $7.56B derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $443.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $3.04B derived: sum of 2 quarters · filed 2022-02-24 | $5.62B derived: sum of 3 quarters · filed 2022-02-24 | $8.05B 10-K · filed 2022-02-24 | $10.22B 10-K · filed 2020-02-27 | |||
| 2019-09-29 | $2.60B 10-Q · filed 2020-11-05 | $5.18B derived: sum of 2 quarters · filed 2020-11-05 | $7.61B 10-Q · filed 2020-11-05 | $8.43B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $2.58B 10-Q · filed 2020-08-06 | $5.01B 10-Q · filed 2020-08-06 | $5.82B derived: sum of 3 quarters · filed 2021-02-25 | $8.52B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $2.43B 10-Q · filed 2020-05-07 | $3.25B derived: sum of 2 quarters · filed 2021-02-25 | $5.94B derived: sum of 3 quarters · filed 2021-02-25 | $8.86B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $814.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.51B derived: sum of 2 quarters · filed 2021-02-25 | $6.42B derived: sum of 3 quarters · filed 2021-02-25 | $8.99B 10-K · filed 2021-02-25 | $11.25B 10-K · filed 2019-02-28 | |||
| 2018-09-30 | $2.69B 10-Q · filed 2019-11-07 | $5.61B derived: sum of 2 quarters · filed 2019-11-07 | $8.17B 10-Q · filed 2019-11-07 | $11.43B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-07-01 | $2.92B 10-Q · filed 2019-08-08 | $5.48B 10-Q · filed 2019-08-08 | $8.73B derived: sum of 3 quarters · filed 2020-02-27 | $11.58B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-04-01 | $2.56B 10-Q · filed 2019-05-09 | $5.82B derived: sum of 2 quarters · filed 2020-02-27 | $8.66B derived: sum of 3 quarters · filed 2020-02-27 | $11.32B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $3.26B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $6.10B derived: sum of 2 quarters · filed 2020-02-27 | $8.76B derived: sum of 3 quarters · filed 2020-02-27 | $11.23B 10-K · filed 2020-02-27 | ||||
| 2017-10-01 | $2.84B 10-Q · filed 2018-11-08 | $5.50B derived: sum of 2 quarters · filed 2018-11-08 | $7.97B 10-Q · filed 2018-11-08 | |||||
| 2017-07-02 | $2.66B 10-Q · filed 2018-08-09 | $5.13B 10-Q · filed 2018-08-09 | ||||||
| 2016-12-31 | $12.32B 10-K · filed 2019-02-28 | |||||||
| 2014-03-30 | $2.04B 10-Q · filed 2014-05-08 | $4.84B derived: sum of 2 quarters · filed 2014-05-08 | $7.13B derived: sum of 3 quarters · filed 2014-05-08 | $9.37B derived: sum of 4 quarters · filed 2014-05-08 | ||||
| 2013-12-31 | $2.79B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $5.08B derived: sum of 2 quarters · filed 2014-02-28 | $7.32B derived: sum of 3 quarters · filed 2014-02-28 | $9.59B 10-K · filed 2014-02-28 | ||||
| 2013-09-29 | $2.29B 10-Q · filed 2013-11-08 | $4.53B derived: sum of 2 quarters · filed 2013-11-08 | $6.79B 10-Q · filed 2013-11-08 | $9.54B derived: sum of 4 quarters · filed 2014-05-08 | ||||
| 2013-06-30 | $2.24B 10-Q · filed 2013-08-09 | $4.50B 10-Q · filed 2013-08-09 | $7.26B derived: sum of 3 quarters · filed 2014-05-08 | $9.57B derived: sum of 4 quarters · filed 2014-05-08 | ||||
| 2013-03-31 | $2.26B 10-Q · filed 2014-05-08 | $2.65B 10-Q · filed 2013-05-10 | $5.02B derived: sum of 2 quarters · filed 2014-05-08 | $7.33B derived: sum of 3 quarters · filed 2014-05-08 | $9.70B derived: sum of 4 quarters · filed 2014-05-08 | |||
| 2012-12-31 | $2.75B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $5.06B derived: sum of 2 quarters · filed 2014-02-28 | $7.44B derived: sum of 3 quarters · filed 2014-02-28 | $9.82B 10-K · filed 2014-02-28 | $11.33B 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $2.31B 10-Q · filed 2013-11-08 | $2.67B 10-Q · filed 2012-11-09 | $4.68B derived: sum of 2 quarters · filed 2013-11-08 | $7.07B 10-Q · filed 2013-11-08 | $8.16B 10-Q · filed 2012-11-09 | $9.48B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-07-01 | $2.38B 10-Q · filed 2013-08-09 | $2.75B 10-Q · filed 2012-08-09 | $4.76B 10-Q · filed 2013-08-09 | $5.50B 10-Q · filed 2012-08-09 | $7.17B derived: sum of 3 quarters · filed 2014-02-28 | $10.58B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-04-01 | $2.75B 10-Q · filed 2013-05-10 | $2.97B 10-Q · filed 2012-05-10 | $4.80B derived: sum of 2 quarters · filed 2014-02-28 | $8.21B derived: sum of 3 quarters · filed 2014-02-28 | $11.78B derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2011-12-31 | $2.05B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $5.46B derived: sum of 2 quarters · filed 2014-02-28 | $9.03B derived: sum of 3 quarters · filed 2014-02-28 | $12.50B 10-K · filed 2014-02-28 | $15.09B 10-K · filed 2012-02-28 | |||
| 2011-10-02 | $3.41B 10-Q · filed 2012-11-09 | $3.68B 10-Q · filed 2011-11-10 | $6.98B derived: sum of 2 quarters · filed 2012-11-09 | $10.45B 10-Q · filed 2012-11-09 | $11.18B 10-Q · filed 2011-11-10 | $13.46B derived: sum of 4 quarters · filed 2013-02-28 | ||
| 2011-07-03 | $3.81B 10-Q · filed 2011-08-11 | $7.04B 10-Q · filed 2012-08-09 | $7.50B 10-Q · filed 2011-08-11 | $10.05B derived: sum of 3 quarters · filed 2013-02-28 | $13.85B derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2011-04-03 | $3.69B 10-Q · filed 2012-05-10 | $6.48B derived: sum of 2 quarters · filed 2013-02-28 | $10.27B derived: sum of 3 quarters · filed 2013-02-28 | $13.96B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $2.79B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $6.58B derived: sum of 2 quarters · filed 2013-02-28 | $10.27B derived: sum of 3 quarters · filed 2013-02-28 | $14.79B 10-K · filed 2013-02-28 | $16.28B 10-K · filed 2011-02-28 | |||
| 2010-10-03 | $3.79B 10-Q · filed 2011-11-10 | $3.90B 10-Q · filed 2010-11-12 | $7.47B derived: sum of 2 quarters · filed 2011-11-10 | $11.68B 10-Q · filed 2011-11-10 | $15.18B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2010-07-04 | $3.68B 10-Q · filed 2011-08-11 | $3.79B 10-Q · filed 2010-08-12 | $7.89B 10-Q · filed 2011-08-11 | $11.39B derived: sum of 3 quarters · filed 2012-02-28 | $13.18B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2010-04-04 | $4.20B 10-Q · filed 2011-05-12 | $4.31B 10-Q · filed 2010-05-13 | $7.71B derived: sum of 2 quarters · filed 2012-02-28 | $9.50B derived: sum of 3 quarters · filed 2012-02-28 | $11.25B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2009-12-31 | $3.51B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $5.29B derived: sum of 2 quarters · filed 2012-02-28 | $7.05B derived: sum of 3 quarters · filed 2012-02-28 | $8.46B 10-K · filed 2012-02-28 | $8.89B 10-K · filed 2010-02-26 | |||
| 2009-09-27 | $1.79B 10-Q · filed 2010-11-12 | $3.54B derived: sum of 2 quarters · filed 2010-11-12 | $4.95B 10-Q · filed 2010-11-12 | $6.67B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-06-28 | $1.76B 10-Q · filed 2010-08-12 | $3.16B 10-Q · filed 2010-08-12 | $4.88B derived: sum of 3 quarters · filed 2011-02-28 | $7.00B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-03-29 | $1.41B 10-Q · filed 2010-05-13 | $3.12B derived: sum of 2 quarters · filed 2011-02-28 | $5.25B derived: sum of 3 quarters · filed 2011-02-28 | $7.53B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2008-12-31 | $1.72B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $3.84B derived: sum of 2 quarters · filed 2011-02-28 | $6.13B derived: sum of 3 quarters · filed 2011-02-28 | $8.11B 10-K · filed 2011-02-28 | ||||
| 2008-09-28 | $2.12B 10-Q · filed 2009-11-05 | $4.41B derived: sum of 2 quarters · filed 2009-11-05 | $6.40B 10-Q · filed 2009-11-05 | |||||
| 2008-06-29 | $2.29B 10-Q · filed 2009-08-06 | $4.28B 10-Q · filed 2009-08-06 | ||||||
| 2007-12-31 | $11.24B 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |